Literature DB >> 638888

Disopyramide phosphate: is it just another quinidine.

T Kus, B I Sasyniuk.   

Abstract

We compared the effects of a therapeutic concentration of disopyramide with those of quinidine and lidocaine on the action potential characteristics and on the steady-state relationship between membrane potential and the maximum rate of rise of the action potential in the same normal Purkinje fiber in which constant impalement was maintained for more than 7 h. All the drugs depressed the steady-state upstroke velocity in the following order of magnitude: quinidine greater than disopyramide greater than lidocaine. Both lidocaine and disopyramide shifted the normalized steady-state curve to more negative membrane potentials indicating a greater depression of upstroke velocity at lower membrane potentials. Quinidine did not shift this curve. Lidocaine abbreviated all phases of repolarization while both disopyramide and quinidine shortened the plateau phase and lengthened the terminal phase of the action potential. The results suggest that the actions of disopyramide on upstroke velocity resemble those of lidocaine, while its effects on action potential duration resemble those of quinidine. The actions of this drug are therefore more complex than previously assumed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638888     DOI: 10.1139/y78-049

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

1.  The activation gate of the sodium channel controls blockade and deblockade by disopyramide in rabbit Purkinje fibres.

Authors:  R Gruber; E Carmeliet
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

2.  The effects of external and internal application of disopyramide on the ionic currents of the squid giant axon.

Authors:  J R Elliott; B M Hendry
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

3.  A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy.

Authors:  M Finlay
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-05       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.